Follow
Benjamin Yongcheng Tan
Benjamin Yongcheng Tan
Anatomical Pathologist, Department of Pathology, Singapore General Hospital
Verified email at singhealth.com.sg
Title
Cited by
Cited by
Year
Phyllodes tumours of the breast: a consensus review
BY Tan, G Acs, SK Apple, S Badve, IJ Bleiweiss, E Brogi, JP Calvo, ...
Histopathology 68 (1), 5-21, 2016
4382016
The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group
K El Bairi, HR Haynes, E Blackley, S Fineberg, J Shear, S Turner, ...
NPJ breast cancer 7 (1), 150, 2021
1392021
Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC
J Yeong, T Tan, ZL Chow, Q Cheng, B Lee, A Seet, JX Lim, JCT Lim, ...
Journal of Clinical Pathology 73 (9), 557-562, 2020
652020
A diagnostic approach to fibroepithelial breast lesions
BY Tan, PH Tan
Surgical Pathology Clinics 11 (1), 17-42, 2018
582018
Clinicopathologic characteristics of solid papillary carcinoma of the breast
BY Tan, AA Thike, IO Ellis, PH Tan
The American journal of surgical pathology 40 (10), 1334-1342, 2016
472016
Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients
VCY Koh, JCT Lim, AA Thike, PY Cheok, MMM Thu, VKM Tan, BKT Tan, ...
Breast cancer research and treatment 152, 293-304, 2015
282015
Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-DM1 In Vivo
JJ Zoeller, A Vagodny, K Taneja, BY Tan, N O'Brien, DJ Slamon, ...
Molecular cancer therapeutics 18 (6), 1115-1126, 2019
252019
The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial
R Barroso-Sousa, WT Barry, H Guo, D Dillon, YB Tan, K Fuhrman, ...
Annals of Oncology 30 (4), 575-581, 2019
232019
Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer
JJ Zoeller, A Vagodny, VW Daniels, K Taneja, BY Tan, YS DeRose, ...
Breast Cancer Research 22, 1-13, 2020
202020
Morphologic and genetic heterogeneity in breast fibroepithelial lesions—a comprehensive mapping study
BY Tan, NDM Nasir, HY Chang, CCY Ng, P Guan, S Nagarajan, ...
Modern Pathology 33 (9), 1732-1745, 2020
192020
Regional registration of whole slide image stacks containing major histological artifacts
M Paknezhad, SYM Loh, Y Choudhury, VKC Koh, TTK Yong, HS Tan, ...
BMC bioinformatics 21 (1), 558, 2020
142020
Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma
K Chen, BL Lee, HH Huang, BY Tan, LS Lee, LG Ng, W Lau, JSP Yuen
International Journal of Urology 24 (1), 51-58, 2017
142017
Solid papillary carcinoma (in situ and invasive)
G Mac Grogan, LC Collins, M Lerwill, EA Rakha, BY Tan
WHO classification of tumours editorial board. Breast Tumours, Lyon (France …, 2019
122019
Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low‐grade lesions: recommendations from the International …
SB Fox, F Webster, CJ Chen, B Chua, L Collins, MP Foschini, ...
Histopathology 81 (4), 467-476, 2022
112022
Encapsulated papillary carcinoma
G Mac Grogan, LC Collins, M Lerwill, EA Rakha, BY Tan
WHO classification of tumours editorial board. Breast Tumours, Lyon (France …, 2019
102019
Survey of recurrent diagnostic challenges in breast phyllodes tumours
BY Tan, SB Fox, SR Lakhani, PH Tan
Histopathology 82 (1), 95-105, 2023
72023
Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor
CL Cheng, ND Md Nasir, GJZ Ng, KWJ Chua, Y Li, J Rodrigues, AA Thike, ...
Laboratory Investigation 102 (3), 245-252, 2022
62022
Special Histologic Type and Rare Breast Tumors–Diagnostic Review and Clinico-Pathological Implications
BY Tan, EH Lim, PH Tan
Surgical Pathology Clinics 15 (1), 29-55, 2022
32022
Multiparametric MRI reporting using prostate imaging reporting and data system version 2.0 (PI-RADSv2) retains clinical efficacy in a predominantly post-biopsy patient population
EJ Aslim, YM Law, PH Tan, JC Allen Jr, LTE Cheng, VA Chidambaram, ...
Asian Journal of Urology 6 (3), 256-263, 2019
32019
An update on the classification of phyllodes tumours of the breast
FF Cheo, YB Tan, PH Tan
Diagnostic Histopathology 28 (3), 119-125, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20